Li Y-R*, Zeng S*, Dunn ZS, Zhou Y, Li Z, Yu J, Wang Y-C, Ku J, Cook N, Kramer A, and Yang L. (*Co-first authors) Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers. iScience. 2022, 25(9):104859. doi: 10.1016/j.isci.2022.104859. [iScience PDF][UCLA News PDF]
